Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo

Journal of Clinical Investigation

Volumn 106, Issue 4, 2000, Pages 493-499

  Luo, Zhengyu ^a   Fujio, Yasushi ^a   Kureishi, Yasuko ^a   Rudic, Radu Daniel ^b   Daumerie, Geraldine ^b   Fulton, David ^b   Sessa, William C ^b   Walsh, Kenneth ^a,c  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BETA GALACTOSIDASE; GLYCERYL TRINITRATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOGRAPHY; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; DOPPLER FLOWMETRY; ENZYME ACTIVITY; ENZYME REGULATION; GENE TRANSFER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033857388     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9419     Document Type: Article

References (35)

1. Moncada, S., Palmer, R.M.J., and Higgs, E.A. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:109-142.
2. Garcia-Cardena, G., et al. 1998. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 392:821-824.
3. Garcia-Cardena, G., Fan, R., Stern, D.F., Liu, J., and Sessa, W.C. 1996. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271:237-27240.
4. Corson, M.A., et al. 1996. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ. Res. 79:984-991.
5. Coffer, P.J., Jin, J., and Woodgett, J.R. 1998. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335:1-13.
6. Fujio, Y., Nguyen, T., Wencker, D., Kitsis, R.N., and Walsh, K. 2000. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 101:660-667.
7. Dudek, H., et al. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:661-665.
8. Kauffman-Zeh, A., et al. 1997. Suppression of c-Myc induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 385:544-548.
9. Kennedy, S.G., et al. 1997. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11:710-713.
10. Fujio, Y., and Walsh, K. 1999. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 274-16349-16354.
11. Gerber, H.-P., et al. 1998. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for FlK-1/KDR activation. J. Biol. Chem. 273:30336-30343.
12. Fulton, D., et al. 1999. Regualtion of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 399:597-601.
13. Dimmelet, S., et al. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 399:601-605.
14. Fujio, Y., et al. 1999. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol. Cell. Biol. 19:5073-5082.
15. CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11:1674-1689.
16. Rivard, A., et al. 1999. Early cell loss after angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wall. Hum. Gene Ther. 10:711-721.
17. Doucette, J.W., et al. 1992. Validation of a Doppler wire for intravascular measurements of coronary artery flow velocity. Circulation. 85:1899-1911.
18. Arnold, W., Mittal, C., Katsuki, S., and Murad, F. 1977. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA. 74:3203-3207.
19. Martin, W., Villani, G.M., Jothianandan, D., and Furchgott, R.F. 1985. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232:708-716.
20. Bauters, C., et al. 1994. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267:H1263-H1271.
21. Huang, P.L., et al. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:239-242.
22. Singer, H., and Peach, M. 1982. Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension. 3:19-25.
23. Papapetropoulos, A., Garcia-Cardena, G., Madri, J.A., and Sessa, W.C. 1997. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100:3131-3139.
24. Michell, B.J., et al. 1999. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9:845-848.
25. Ohashi, Y., et al. 1998. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J. Clin. Invest. 102:2061-2071.
26. Ooboshi, H., Toyoda, K., Faraci, F.M., Lang, M.G., and Heistad, D.D. 1998. Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 18:1752-1758.
27. Kullo, I.J., et al. 1997. Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. Hypertension. 30:314-320.
28. Channon, K.M., et al. 1998. In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-fed rabbits. Circulation. 98:1905-1911.
29. Dimmeler, S., Haendeler, J., Nehls, M., and Zeiher, A.M. 1997. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE) like and cysteine protease protein (CPP)-32 like proteases. J. Exp. Med. 185:601-607.
30. Simon, D.I., et al. 1993. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler. Thromb. 13:791-799.
31. Qian, H.S., Neplioueva, V., Shetty, G.A., Channon, K.M., and George, S.E. 1999. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation. 99:2979-2982.
32. von der Leyen, H.E., et al. 1995. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA. 92:1137-1141.
33. Guo, K., Andrés, V., and Walsh, K. 1998. Nitric oxide-induced down-regulation of cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells. Circulation. 20:2066-2072.
34. Heistad, D.D., Armstrong, M.L., Marcus, M.L., Piegors, D.J., and Mark, A.L. 1984. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ. Res. 54:711-718.
35. McLenachan, J.M., Williams, J.K., Fisher, R.D., Ganz, P., and Selwyn, A.P. 1991. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation. 84:1273-1278.